Abstract |
Hyperammonemia after lung transplantation is a rare complication of unknown etiology. Its management is largely supportive and outcomes have been variable. More disconcerting is its immunosuppressive management because the precipitating factors leading to this potentially lethal entity are unknown, but are suspected to be drug-related. We describe the successful management of a lung transplant recipient with severe hyperammonemia.
|
Authors | Susan D Moffatt-Bruce, Todd Pesavento, John Von Viger, David Nunley, Amy Pope-Harman, Stanley Martin, Patrick Ross |
Journal | The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
(J Heart Lung Transplant)
Vol. 27
Issue 7
Pg. 801-3
(Jul 2008)
ISSN: 1557-3117 [Electronic] United States |
PMID | 18582813
(Publication Type: Case Reports, Journal Article)
|
Chemical References |
- Immunosuppressive Agents
- Ammonia
|
Topics |
- Ammonia
(blood)
- Humans
- Hyperammonemia
(etiology, therapy)
- Immunosuppressive Agents
(therapeutic use)
- Lung Transplantation
(adverse effects)
- Male
- Middle Aged
|